Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

A research consortium in which Professor Anna Gloyn is a member has been awarded EU funding of €5.99 million as part of the Horizon 2020 Research and Innovation Framework Progamme.

The consortium which involves eleven partners will “Develop a systems biomedicine approach for risk identification, prevention and treatment of type 2 diabetes -T2DSystems”.

We want to hear about your news!

Publishing a paper? Just won an award? Get in touch with communications@rdm.ox.ac.uk

 

Similar stories

New study reveals role of lymphatic system in bone healing

Bones were thought to lack lymphatic vessels, but new research from the Kusumbe Group published in Cell not only locates them within bone tissue, but demonstrates their role in bone and blood cell regeneration and reveals changes associated with aging.

Anjali Kusumbe receives Women in Cell Biology Early Career Medal

Founded in 2015 to mark the 50th anniversity of the founding of the British Society for Cell Biology, the award recognises outstanding early career biologists.

New Studentship honours Enzo Cerundolo

A new Studentship has been announced in memory of the late MRC HIU Director and MRC WIMM Group Leader.

Doug Higgs awarded the 2023 Genetics Society Medal

The award recognises Professor Higgs' major contribution to our understanding of how mammalian genes are switched on and off, and using haematopoiesis as a model to understand how genes function.